Trials / Completed
CompletedNCT03465553
Palliative Short Course Radiotherapy for Advanced Thoracic Cancer
Palliative Short Course Accelerated Radiation Therapy for Advanced Thoracic Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study wants to define the maximum tolerated dose (MTD), safety and efficacy of a short course radiation therapy in patients with symptomatic advanced thoracic cancer.
Detailed description
The study wants to define the maximum tolerated dose (MTD) of a conformal short course accelerated radiation therapy delivered in twice daily fractions and 2 consecutive days, and the feasibility of this fractionation in term of safety and efficacy for symptomatic palliation of advanced thoracic cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Short course radiotherapy | An accelerated hypo-fractionation radiotherapy is delivered for palliation in patients with advanced thoracic cancer |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2018-03-14
- Last updated
- 2018-03-14
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03465553. Inclusion in this directory is not an endorsement.